Ainos, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AIMD research report →
Price Chart
About the company
Ainos, Inc. operates as a healthcare technology company, specializing in point-of-care diagnostics and the development of safe, novel treatments for various disease indications. Its current portfolio encompasses a COVID-19 antigen rapid test kit, which integrates with a cloud-based test management platform known as the Ainos App, offering both personal and enterprise applications.
- CEO
- Chun-Hsien Tsai
- IPO
- 2021
- Employees
- 41
- HQ
- Houston, TX, US
Get TickerSpark's AI analysis on AIMD
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $8.93M
- P/E
- -0.55
- PEG
- -0.01
- P/S
- 13.64
- P/B
- 5.09
- EV/EBITDA
- -2.44
- Div Yield
- 0.00%
- Gross Margin
- -461.10%
- Op Margin
- -1935.60%
- Net Margin
- -2049.28%
- ROE
- -293.74%
- ROIC
- -99.56%
Latest fiscal year · YoY change
- Revenue
- $124.16K+499.0%
- Gross Profit
- $-4,677,239-14577.8%
- Op Income
- $-13,990,408
- Net Income
- $-14,771,012+0.6%
- EPS
- $-3.46-121.8%
- OCF Growth
- +20.5%
- FCF Growth
- +20.2%
- 52W High
- $3.88
- 52W Low
- $0.43
- 50D MA
- $1.07
- 200D MA
- $1.52
- Beta
- 2.69
- RSI (14)
- 59
- Avg Volume
- 1.87M
No earnings-call transcripts are available for AIMD yet.
- Free Float
- 46.7%
- Shares Outstanding
- 7.57M
- Float Shares
- 3.53M
of shares held by institutions
14 13F filers
Buy/sell ratio 1.67. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Geode Capital Management, LLC | 43.89K | ▼ 194 |
| Vanguard Capital Management LLC | 33.94K | ▲ 17.91K |
| Envestnet Asset Management Inc | 31.60K | ▲ 31.60K |
| Principal Securities, Inc. | 31.60K | ▲ 31.60K |
| Keystone Financial Group | 25.25K | ▼ 300 |
| Vanguard Group Inc | 24.23K | ▼ 522 |
| Mariner, LLC | 15.80K | 0 |
| Vanguard Fiduciary Trust Co | 14.17K | 0 |
| Blackrock, Inc. | 3.06K | 0 |
| Citigroup Inc | 1.70K | ▲ 1.52K |
| Tower Research Capital LLC (Trc) | 1.68K | ▼ 1.47K |
| Steward Partners Investment Advisory, LLC | 1.21K | 0 |
Held by 5 ETFs
Biggest fund positions in AIMD by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 5, 26 | chiang yao-chung | buy | 3,500 |
| Jun 3, 26 | chiang yao-chung | buy | 2,000 |
| May 28, 26 | chiang yao-chung | buy | 250 |
| May 27, 26 | chiang yao-chung | buy | 2,000 |
| May 26, 26 | lee ting-chuan | sell | 109,988 |
| May 26, 26 | Taiwan Carbon Nano Technology Corp | sell | 41,000 |
| May 22, 26 | TSAI CHUN-JUNG | sell | 1,082 |
| May 26, 26 | TSAI CHUN-JUNG | sell | 27,718 |
| May 21, 26 | lee ting-chuan | sell | 9,000 |
| May 22, 26 | lee ting-chuan | sell | 9,302 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our AIMD coverage
Recent articles, reports, and earnings notes.
No research on AIMD yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate AIMD report →Ainos Completes VELDONA Technology Transfer, Triggering $600,000 License Payment
accessnewswire.com · Sep 30
Ainos Completes Delivery of 1,400 AI Nose Systems to ASE Under $2.1 Million, Three-Year Contract
accessnewswire.com · Sep 29
Ainos Details Partner-Funded VELDONA Development and Revenue Opportunities, Reinforcing Focus on Chemical Intelligence
accessnewswire.com · Sep 28
Ainos, Inc. (NASDAQ:AIMD) Shares Shorted: Short Interest Up 172.6% in September
defenseworld.net · Sep 27
Ainos and BioPhoenix Sign VELDONA License Agreement, Establishing a Potential $10 Million Collaboration Framework
accessnewswire.com · Sep 24
VASRO Research Highlights Ainos' New Order, Semiconductor Commercial Momentum and 1 Billion+ Chemical Dataset
accessnewswire.com · Sep 16
Ainos Advances AI Nose into Commercial Deployment in Front-End Semiconductor Manufacturing
accessnewswire.com · Sep 14
Ainos Secures Three Japanese Robotics Patents, Advancing Chemical Perception for the Physical AI Era
accessnewswire.com · Sep 9
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.